AI model aims to end guesswork in colorectal cancer chemo
NCT ID NCT07226115
First seen Nov 10, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study is developing a computer model that uses genetic information from tumors to predict which colorectal cancer patients will benefit from chemotherapy after surgery. The goal is to avoid giving chemo to those who won't respond, while ensuring those who need it get the right treatment. Researchers will analyze tumor samples from 200 patients with stage II or III colorectal cancer to find patterns linked to recurrence and survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.